GB9808896D0 - Novel compound - Google Patents

Novel compound

Info

Publication number
GB9808896D0
GB9808896D0 GBGB9808896.6A GB9808896A GB9808896D0 GB 9808896 D0 GB9808896 D0 GB 9808896D0 GB 9808896 A GB9808896 A GB 9808896A GB 9808896 D0 GB9808896 D0 GB 9808896D0
Authority
GB
United Kingdom
Prior art keywords
novel compound
novel
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9808896.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9808896.6A priority Critical patent/GB9808896D0/en
Publication of GB9808896D0 publication Critical patent/GB9808896D0/en
Priority to EP99918151A priority patent/EP1089995A1/en
Priority to IL13908199A priority patent/IL139081A0/xx
Priority to TR2000/03084T priority patent/TR200003084T2/xx
Priority to AU36184/99A priority patent/AU3618499A/en
Priority to APAP/P/2000/001963A priority patent/AP2000001963A0/en
Priority to SK1591-2000A priority patent/SK15912000A3/sk
Priority to CA002330055A priority patent/CA2330055A1/en
Priority to CN99805160A priority patent/CN1297448A/zh
Priority to JP2000545858A priority patent/JP2002513019A/ja
Priority to IDW20002169A priority patent/ID26654A/id
Priority to PCT/GB1999/001244 priority patent/WO1999055698A1/en
Priority to BR9909868-7A priority patent/BR9909868A/pt
Priority to KR1020007011809A priority patent/KR20010042977A/ko
Priority to EA200001104A priority patent/EA200001104A1/ru
Priority to HU0102116A priority patent/HUP0102116A3/hu
Priority to IDW20002168A priority patent/ID26083A/id
Priority to PL99343677A priority patent/PL343677A1/xx
Priority to ZA200005912A priority patent/ZA200005912B/en
Priority to NO20005352A priority patent/NO20005352L/no
Priority to BG104940A priority patent/BG104940A/bg
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9808896.6A 1998-04-25 1998-04-25 Novel compound Ceased GB9808896D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound
PL99343677A PL343677A1 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate
IDW20002169A ID26654A (id) 1998-04-25 1999-04-23 Paroksetin askorbat
BR9909868-7A BR9909868A (pt) 1998-04-25 1999-04-23 Ascorbato de paroxetina
TR2000/03084T TR200003084T2 (tr) 1998-04-25 1999-04-23 Paroxetine askorbat
AU36184/99A AU3618499A (en) 1998-04-25 1999-04-23 Paroxetine ascorbate
APAP/P/2000/001963A AP2000001963A0 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate.
SK1591-2000A SK15912000A3 (sk) 1998-04-25 1999-04-23 Askorbát paroxetínu, spôsob jeho výroby a jeho použitie
CA002330055A CA2330055A1 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate
CN99805160A CN1297448A (zh) 1998-04-25 1999-04-23 帕罗西汀抗坏血酸盐
JP2000545858A JP2002513019A (ja) 1998-04-25 1999-04-23 パロキセチン・アスコルビン酸塩
EP99918151A EP1089995A1 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate
PCT/GB1999/001244 WO1999055698A1 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate
IL13908199A IL139081A0 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate
KR1020007011809A KR20010042977A (ko) 1998-04-25 1999-04-23 파록세틴 아스코르베이트
EA200001104A EA200001104A1 (ru) 1998-04-25 1999-04-23 Аскорбат пароксетина
HU0102116A HUP0102116A3 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate, process for its preparation and its pharmaceutical use
IDW20002168A ID26083A (id) 1998-04-25 1999-04-23 Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns
ZA200005912A ZA200005912B (en) 1998-04-25 2000-10-23 Paroxetine ascorbate.
NO20005352A NO20005352L (no) 1998-04-25 2000-10-24 Paroksetinaskorbat
BG104940A BG104940A (bg) 1998-04-25 2000-11-13 Пароксетин аскорбат

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound

Publications (1)

Publication Number Publication Date
GB9808896D0 true GB9808896D0 (en) 1998-06-24

Family

ID=10831008

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9808896.6A Ceased GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound

Country Status (20)

Country Link
EP (1) EP1089995A1 (id)
JP (1) JP2002513019A (id)
KR (1) KR20010042977A (id)
CN (1) CN1297448A (id)
AP (1) AP2000001963A0 (id)
AU (1) AU3618499A (id)
BG (1) BG104940A (id)
BR (1) BR9909868A (id)
CA (1) CA2330055A1 (id)
EA (1) EA200001104A1 (id)
GB (1) GB9808896D0 (id)
HU (1) HUP0102116A3 (id)
ID (2) ID26654A (id)
IL (1) IL139081A0 (id)
NO (1) NO20005352L (id)
PL (1) PL343677A1 (id)
SK (1) SK15912000A3 (id)
TR (1) TR200003084T2 (id)
WO (1) WO1999055698A1 (id)
ZA (1) ZA200005912B (id)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
JP4508646B2 (ja) * 2002-01-09 2010-07-21 エミスフェアー・テクノロジーズ・インク ４−［（４−クロロ−２−ヒドロキシベンゾイル）アミノ］ブタン酸ナトリウムの多形体
CN110607554B (zh) * 2018-10-30 2024-03-22 中国科学院化学研究所 一种制备药物或药物中间体单晶或无定型物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.

Also Published As

Publication number Publication date
PL343677A1 (en) 2001-08-27
BR9909868A (pt) 2000-12-19
NO20005352D0 (no) 2000-10-24
JP2002513019A (ja) 2002-05-08
SK15912000A3 (sk) 2001-04-09
TR200003084T2 (tr) 2001-02-21
AP2000001963A0 (en) 2000-12-31
CN1297448A (zh) 2001-05-30
ZA200005912B (en) 2001-12-19
NO20005352L (no) 2000-10-24
WO1999055698A1 (en) 1999-11-04
ID26654A (id) 2001-01-25
HUP0102116A2 (hu) 2002-05-29
KR20010042977A (ko) 2001-05-25
EP1089995A1 (en) 2001-04-11
AU3618499A (en) 1999-11-16
HUP0102116A3 (en) 2002-12-28
IL139081A0 (en) 2001-11-25
BG104940A (bg) 2001-09-28
EA200001104A1 (ru) 2001-04-23
ID26083A (id) 2000-11-23
CA2330055A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
GB9801392D0 (en) Novel compounds
GB9920332D0 (en) Novel compound
GB9805348D0 (en) Compound
GB9827431D0 (en) Novel compound
GB9808268D0 (en) Compound
GB9808896D0 (en) Novel compound
GB9808894D0 (en) Novel compound
GB9823175D0 (en) Compound
GB9817321D0 (en) Novel compound
GB9817323D0 (en) Novel compound
GB9821732D0 (en) Novel compound
GB9823856D0 (en) Novel compound
GB9826172D0 (en) Novel compound
GB9827277D0 (en) Novel compound
GB9820404D0 (en) Novel compound
GB9817310D0 (en) Novel compound
GB9817307D0 (en) Novel compound
GB9815871D0 (en) Novel compound
GB9817338D0 (en) Novel compound
GB9817337D0 (en) Novel compound
GB9800317D0 (en) Novel compounds
GB9802533D0 (en) Novel compounds
GB9800324D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9801635D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)